Haemophilus pleuropneumoniae serotypes--cross protection experiments.

Area of Science:

• Veterinary Immunology
• Bacteriology

Background:

• Haemophilus pleuropneumoniae causes significant respiratory disease in swine.
• Intranasal immunization with live H. pleuropneumoniae has previously shown strong homologous and heterologous immunity.
• Parenteral vaccination strategies require further investigation for efficacy.

Purpose of the Study:

• To evaluate the efficacy of parenteral vaccination against Haemophilus pleuropneumoniae.
• To determine if cross-serotype immunity is induced by killed H. pleuropneumoniae vaccines.
• To compare immune responses from parenteral vaccination versus natural infection.

Main Methods:

• Pigs were vaccinated with killed Haemophilus pleuropneumoniae serotype 2, 4, or 5 with Freund's incomplete adjuvant.
• Vaccinated pigs were challenged with homologous and heterologous serotypes of H. pleuropneumoniae.
• Immune protection was assessed based on challenge outcomes.

Main Results:

• Parenteral vaccination with killed H. pleuropneumoniae did not provide protection against heterologous serotype challenges.
• A vaccine containing serotypes 1-6 showed protection against serotypes 2, 3, and 8, indicating serotype-specific immunity.
• Results suggest parenteral immunization elicits a different immune response than natural infection.

Conclusions:

• Cross-immunity is not achieved through parenteral immunization with H. pleuropneumoniae vaccines.
• The findings highlight the importance of a local immune barrier in preventing mucosal penetration.
• Future vaccine development should focus on including prevalent serotypes found in swine populations for effective disease control.